Wilson Sonsini advised Droplet Biosciences on the deal.Droplet Biosciences announced an $8 million seed investment to establish proof of concept for the company’s lymph diagnostic platform…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
